前列腺癌挽救性放疗前多参数MRI的预后价值、敏感性与特异性
本研究回顾386例根治性前列腺切除术后生化复发、接受挽救性放疗前多参数MRI的患者,评估MRI表现与生化复发、远处转移、前列腺癌特异性死亡及挽救性ADT使用的关系,并计算MRI检测局部复发的敏感性与特异性。结果显示MRI阳性或不确定与更好的生化控制相关,敏感性61.0%、特异性60.0%。
要点
- 挽救性放疗前MRI阳性或不确定与更低的生化复发风险相关。
- MRI检测局部复发的敏感性61.0%、特异性60.0%、PPV 86.1%、NPV 27.6%。
- 敏感性在挽救前PSA>1.0者中更高(80.0%),特异性在PSA 0.1-0.5者中更高(73.9%)。
核心结论
- 挽救性放疗前MRI阳性或不确定与更好的生化控制相关,且不受PSA水平影响。
- MRI检测局部复发的敏感性为61.0%、特异性为60.0%(摘要结论部分写为58.7%)。
研究设计与样本
- 回顾性队列研究,纳入386例根治性前列腺切除术后生化复发、挽救性放疗前接受盆腔MRI的患者。
主要发现
- MRI阳性216例(56%)、不确定46例(12%)、阴性124例(32%)。
- 与MRI阴性相比,阳性者生化复发风险显著更低(HR 0.58,95%CI 0.42-0.8),不确定者HR 0.6(95%CI 0.36-1),p=0.003。
- 多因素分析及不同挽救前PSA亚组中上述关联仍显著(p<0.05)。
- 全队列MRI检测局部复发的敏感性61.0%(95%CI 53.5-68.1%)、特异性60.0%(95%CI 44.3-73.0%)、PPV 86.1%(95%CI 78.9-91.5%)、NPV 27.6%(95%CI 19.0-37.5%)。
- 敏感性在挽救前PSA>1.0者中为80.0%,特异性在PSA 0.1-0.5者中为73.9%。
关键数值与推荐
- MRI阳性定义:216例(56%)报告局部复发;不确定46例(12%);阴性124例(32%)。
- 生化复发风险比较:阳性vs阴性HR 0.58(95%CI 0.42-0.8),不确定vs阴性HR 0.6(95%CI 0.36-1),p=0.003。
- 诊断效能:敏感性61.0%(53.5-68.1%)、特异性60.0%(44.3-73.0%)、PPV 86.1%(78.9-91.5%)、NPV 27.6%(19.0-37.5%)。
- 亚组:PSA>1.0者敏感性80.0%;PSA 0.1-0.5者特异性73.9%。
临床怎么用
- 挽救性放疗前可考虑行盆腔MRI评估局部复发,阳性或不确定结果提示较好的生化控制预期。
- MRI阴性时NPV较低(27.6%),需结合PSA等临床信息综合判断。
- 高PSA(>1.0)患者MRI敏感性较高,低PSA(0.1-0.5)患者特异性较高。
局限性
- 回顾性研究设计。
- 摘要未报告远处转移、前列腺癌特异性死亡及挽救性ADT使用的具体结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To determine the operational characteristics of pelvic magnetic resonance imaging (MRI) prior to salvage radiation therapy (SRT) for biochemically recurrent prostate cancer following radical prostatectomy. METHODS AND MATERIALS: We reviewed the medical records of 386 patients who underwent MRI prior to SRT. We assessed associations of pre-SRT MRI findings with biochemical recurrence (BCR), distant metastasis (DM), prostate cancer-specific mortality (PCSM), and salvage androgen deprivation therapy (ADT) use following SRT. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MRI for detecting local recurrence were also calculated. RESULTS: Pre-SRT MRI was positive for local recurrence in 216 patients (56%), indeterminate in 46 (12%), and negative in 124 (32%). On univariate analysis, BCR following SRT was significantly less likely for patients with positive (HR: 0.58, 95% CI: 0.42-0.8) or indeterminate (HR: 0.6: 0.36-1) MRI findings, compared to patients with negative imaging (p = 0.003). These associations remained significant on multivariate analysis (p < 0.05) and across pre-SRT PSA groups. For the entire cohort, the sensitivity of MRI for local recurrence was 61.0% (53.5-68.1%), specificity 60.0% (44.3-73.0%), PPV 86.1% (78.9-91.5%) and NPV 27.6% (19.0-37.5%). Sensitivity of MRI was better in men with higher pre-SRT PSA (80.0% for PSA > 1.0), and specificity was improved with lower pre-SRT PSA (73.9% for PSA 0.1-0.5). CONCLUSIONS: Positive or indeterminate MRI findings prior to SRT were associated with improved biochemical control following SRT, across PSA levels. The sensitivity and specificity of MRI for local recurrence were 61% and 58.7%, respectively.
引用
- Breen WG, Stish BJ, Harmsen WS, et al. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer. Radiother Oncol. 2021. PMID: 34023327. doi:10.1016/j.radonc.2021.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。